Safety of Compounded Medications.

Area of Science:

• Pharmaceutical Sciences
• Drug Compounding
• Patient Safety

Background:

• Compounded medications address unique patient needs unmet by FDA-approved drugs, such as altered dosages or allergen avoidance.
• These custom preparations fill critical gaps in pharmaceutical care when standard medications are unsuitable.

Discussion:

• Compounded medications face significant safety challenges, including potential contamination and inaccurate potency, stemming from reduced regulatory scrutiny.
• The risks associated with compounded drugs necessitate careful consideration of benefits versus potential harm.

Key Insights:

• Patient safety is compromised by inadequate regulatory oversight and insufficient safety measures in compounding facilities.
• Compounded medications should be reserved for situations where FDA-approved options are unavailable and benefits clearly outweigh risks.

Outlook:

• Enhanced regulatory oversight and stringent safety protocols at compounding sites are essential to mitigate risks.
• Future efforts should focus on balancing the therapeutic benefits of compounded medications with robust safety standards.